RA
CARM

Royce & Associates’s Carisma Therapeutics CARM Stock Holding History

Royce & Associates’s Portfolio CARM Stock Details CARM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-132
Closed -$5K – 1180
2018
Q2 		$5K Sell
132
-12
-8% -$529 ﹤0.01% 1212
2018
Q1 		$3K Buy
+144
New +$2.76K ﹤0.01% 1249
2015
Q2 		– Sell
-19,430
Closed -$3.47M – 1217
2015
Q1 		$3.47M Buy
+19,430
New +$4.25M 0.01% 826

Other funds holding CARM

CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
TG
TRV GP Boston, Massachusetts $18.9M AUM 541.67% 1-Year Est. Return
KCM
Kingdon Capital Management New York $597M AUM 51.11% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
NC
Nexthera Capital New York $120M AUM 10.01% 1-Year Est. Return
CHP
Castle Hook Partners New York $4.95B AUM 158.96% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return